The topoisomerase IIβ circular clamp arrests transcription and signals a 26S proteasome pathway

被引:81
作者
Xiao, H
Mao, Y
Desai, SD
Zhou, N
Ting, CY
Hwang, JL
Liu, LF
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
[2] Acad Sinica, Inst Mol Biol, Taipei, Taiwan
关键词
D O I
10.1073/pnas.0736401100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been proposed that the topoisomerase II (TOP2)beta-DNA covalent complex arrests transcription and triggers 26S proteasome-mediated degradation of TOP2beta. It is unclear whether the initial trigger for proteasomal degradation is due to DNA damage or transcriptional arrest. In the current study we show that the TOP2 catalytic inhibitor 4,4-(2,3-butanediyl)-bis(2,6-piperazinedione) (ICRF-193), which traps TOP2 into a circular clamp rather than the TOP2-DNA covalent complex, can also arrest transcription. Arrest of transcription, which is TOP2beta-dependent, is accompanied by proteasomal degradation of TOP2beta. Different from TOP2 poisons and other DNA-damaging agents, ICRF-193 did not induce proteasomal degradation of the large subunit of RNA polymerase II. These results suggest that proteasomal degradation of TOP2beta induced by the TOP2-DNA covalent complex or the TOP2 circular clamp is due to transcriptional arrest but not DNA damage. By contrast, degradation of the large subunit of RNA polymerase II is due to a DNA-damage signal.
引用
收藏
页码:3239 / 3244
页数:6
相关论文
共 41 条
[1]   Catalytic inhibitors of DNA topoisomerase II [J].
Andoh, T ;
Ishida, R .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :155-171
[2]  
Bauman ME, 1997, MODERN PATHOL, V10, P168
[3]   TOPOISOMERASE-TARGETING ANTITUMOR DRUGS [J].
DARPA, P ;
LIU, LF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) :163-177
[4]   ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase [J].
Deming, PB ;
Flores, KG ;
Downes, CS ;
Paules, RS ;
Kaufmann, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36832-36838
[5]   Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin [J].
Desai, SD ;
Liu, LF ;
VazquezAbad, D ;
DArpa, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) :24159-24164
[6]  
Desai SD, 2001, CANCER RES, V61, P5926
[7]  
DESAI SD, 2003, IN PRESS MOL CELL BI
[8]   BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF P170 AND P180 FORMS OF TOPOISOMERASE-II [J].
DRAKE, FH ;
HOFMANN, GA ;
BARTUS, HF ;
MATTERN, MR ;
CROOKE, ST ;
MIRABELLI, CK .
BIOCHEMISTRY, 1989, 28 (20) :8154-8160
[9]   Murine transgenic cells lacking DNA topoisomerase IIβ are resistant to acridines and mitoxantrone:: Analysis of cytotoxicity and cleavable complex formation [J].
Errington, F ;
Willmore, E ;
Tilby, MJ ;
Li, L ;
Li, G ;
Li, W ;
Baguley, BC ;
Austin, CA .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1309-1316
[10]   The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II [J].
Ferdous, A ;
Gonzalez, F ;
Sun, LP ;
Kodadek, T ;
Johnston, SA .
MOLECULAR CELL, 2001, 7 (05) :981-991